Compound Comparison Table Published Scientific Literature Retatrutide has been referenced in published scientific investigations involving metabolic pathway research, incretin biology, receptor signaling, and triple-receptor agonist models
For further details on these trials, please refer to this study in the New England Journal of Medicine or contact us for additional information
However, retatrutide is most effective at reducing fat mass
Retatrutide should not be used by anyone who is pregnant, breastfeeding, or has an existing health condition
Retatrutide may negatively interact with the following cardiovascular and anti-diabetic medications: Warfarin (Coumadin) Losartan (Cozaar) Valsartan (Diovan) Eprosartan (Teveten) Azilsartan (Edarbi) Candesartan (Atacand) Irbesartan (Avapro) Telmisartan (Micardis) Metoprolol (Lopressor) Atenolol (Tenormin) Propranolol (AY-20694) Captopril (Capoten) Enalapril (Renitec) Lisinopril (Prinivil) Benazepril (Lotensin) Fosinopril (Monopril) Quinapril (Accupril) Ramipril (Altace) Perindopril (Coversum) Moexipril (Univasc) Trandolapril (Mavik) Insulin (Novolin) Glipizide (Glucotrol) Glibenclamide (Glynase) Gliclazide (Diaprel) Does Retatrutide Pose Any Risks to Health
Product Specifications Lot Tracking & Certificate of Analysis Every vial ships with a unique lot number
